Acceder Registro /

ALEJANDRO RIQUELME PEREZ

Buscador

Arnaldos-Carrillo M, Noguera-Velasco JA, Martinez-Ardil IM, Riquelme-Perez A, Cebreiros-Lopez I, Hernandez-Vicente A, Ros-Lucas JA, Khan A, Bayes-Genis A, Pascual-Figal D. Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19. Med Clin (Barc). 2023 Sep 8;161(5):185-191. doi: 10.1016/j.medcli.2023.04.005. Epub 2023 Apr 11. PubMed PMID: 37137804; PubMed Central PMCID: PMC10086099.
AÑO: 2023; IF: 3.9
Pascual-Figal DA, Zamorano JL, Domingo M, Morillas H, Nunez J, Cobo Marcos M, Riquelme-Perez A, Teis A, Santas E, Caro-Martinez C, Pinilla JM, Rodriguez-Palomares JF, Dobarro D, Restrepo-Cordoba MA, Gonzalez-Juanatey JR, Bayes Genis A; DAPA-MODA Study Investigators. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study. Eur J Heart Fail. 2023 Aug;25(8):1352-1360. doi: 10.1002/ejhf.2884. Epub 2023 Jun 7. PubMed PMID: 37211950.
AÑO: 2023; IF: 18.2

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R